BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26338993)

  • 1. Radiation-induced organizing pneumonia after stereotactic body radiotherapy for lung tumor.
    Ochiai S; Nomoto Y; Yamashita Y; Murashima S; Hasegawa D; Kurobe Y; Toyomasu Y; Kawamura T; Takada A; Ii N
    J Radiat Res; 2015 Nov; 56(6):904-11. PubMed ID: 26338993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organizing pneumonia after stereotactic ablative radiotherapy of the lung.
    Murai T; Shibamoto Y; Nishiyama T; Baba F; Miyakawa A; Ayakawa S; Ogino H; Otsuka S; Iwata H
    Radiat Oncol; 2012 Aug; 7():123. PubMed ID: 22853821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early graphical appearance of radiation pneumonitis correlates with the severity of radiation pneumonitis after stereotactic body radiotherapy (SBRT) in patients with lung tumors.
    Takeda A; Ohashi T; Kunieda E; Enomoto T; Sanuki N; Takeda T; Shigematsu N
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):685-90. PubMed ID: 20510193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe COPD is correlated with mild radiation pneumonitis following stereotactic body radiotherapy.
    Takeda A; Kunieda E; Ohashi T; Aoki Y; Oku Y; Enomoto T; Nomura K; Sugiura M
    Chest; 2012 Apr; 141(4):858-866. PubMed ID: 21885726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric factors predicting radiation pneumonitis after CyberKnife stereotactic body radiotherapy for peripheral lung cancer.
    Nakamura M; Nishimura H; Nakayama M; Mayahara H; Uezono H; Harada A; Hashimoto N; Ejima Y; Ishihara T; Sasaki R
    Br J Radiol; 2016 Dec; 89(1068):20160560. PubMed ID: 27805837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival in Patients Treated With Lung Stereotactic Body Radiation Therapy (SBRT).
    Glick D; Lyen S; Kandel S; Shapera S; Le LW; Lindsay P; Wong O; Bezjak A; Brade A; Cho BCJ; Hope A; Sun A; Giuliani M
    Clin Lung Cancer; 2018 Mar; 19(2):e219-e226. PubMed ID: 29066051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot Study of the Safety and Efficacy of Dose Escalation in Stereotactic Body Radiotherapy for Peripheral Lung Tumors.
    Mitsuyoshi T; Matsuo Y; Shintani T; Iizuka Y; Ueki N; Nakamura M; Mizowaki T
    Clin Lung Cancer; 2018 May; 19(3):e287-e296. PubMed ID: 29277565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-Angiotensin System Inhibitors Might Help to Reduce the Development of Symptomatic Radiation Pneumonitis After Stereotactic Body Radiotherapy for Lung Cancer.
    Bracci S; Valeriani M; Agolli L; De Sanctis V; Maurizi Enrici R; Osti MF
    Clin Lung Cancer; 2016 May; 17(3):189-97. PubMed ID: 26427647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiological and clinical pneumonitis after stereotactic lung radiotherapy: a matched analysis of three-dimensional conformal and volumetric-modulated arc therapy techniques.
    Palma DA; Senan S; Haasbeek CJ; Verbakel WF; Vincent A; Lagerwaard F
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):506-13. PubMed ID: 20584582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy.
    Kelley KD; Benninghoff DL; Stein JS; Li JZ; Byrnes RT; Potters L; Knisely JP; Zinkin HD
    Radiat Oncol; 2015 May; 10():120. PubMed ID: 26018408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic body radiotherapy for lung tumors in patients with subclinical interstitial lung disease: the potential risk of extensive radiation pneumonitis.
    Yamaguchi S; Ohguri T; Ide S; Aoki T; Imada H; Yahara K; Narisada H; Korogi Y
    Lung Cancer; 2013 Nov; 82(2):260-5. PubMed ID: 24054547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Pneumonitis After Stereotactic Body Radiation Therapy in Patients With Previous Anatomic Lung Resection.
    Hayes JT; David EA; Qi L; Chen AM; Daly ME
    Clin Lung Cancer; 2015 Sep; 16(5):379-84. PubMed ID: 25737143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic body radiation therapy can be used safely to boost residual disease in locally advanced non-small cell lung cancer: a prospective study.
    Feddock J; Arnold SM; Shelton BJ; Sinha P; Conrad G; Chen L; Rinehart J; McGarry RC
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1325-31. PubMed ID: 23265574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simple Factors Associated With Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy of the Thorax: A Pooled Analysis of 88 Studies.
    Zhao J; Yorke ED; Li L; Kavanagh BD; Li XA; Das S; Miften M; Rimner A; Campbell J; Xue J; Jackson A; Grimm J; Milano MT; Spring Kong FM
    Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1357-1366. PubMed ID: 27325482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeat stereotactic body radiation therapy for patients with pulmonary malignancies who had previously received SBRT to the same or an adjacent tumor site.
    Valakh V; Miyamoto C; Micaily B; Chan P; Neicu T; Li S
    J Cancer Res Ther; 2013; 9(4):680-5. PubMed ID: 24518717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer: A Retrospective, Single-Center Study of 55 Patients.
    Bhandari RP; Stanford JD; Packianathan S; Duggar WN; Kanakamedala MR; Zhang X; Giri SP; Kumar PP; Harrell LM; Mangana SH; Yang C; Vijayakumar S
    Oncology; 2016; 91(4):194-204. PubMed ID: 27427761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy.
    Ricardi U; Filippi AR; Guarneri A; Giglioli FR; Mantovani C; Fiandra C; Anglesio S; Ragona R
    Acta Oncol; 2009; 48(4):571-7. PubMed ID: 19031164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic body radiotherapy with helical TomoTherapy for medically inoperable early stage primary and second-primary non-small-cell lung neoplasm: 1-year outcome and toxicity analysis.
    Casutt A; Bouchaab H; Beigelman-Aubry C; Bourhis J; Lovis A; Matzinger O
    Br J Radiol; 2015 May; 88(1049):20140687. PubMed ID: 25735428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excellent Cancer Outcomes Following Patient-adapted Robotic Lung SBRT But a Case for Caution in Idiopathic Pulmonary Fibrosis.
    Bahig H; Filion E; Vu T; Roberge D; Lambert L; Bouchard M; Lavoie C; Doucet R; Nadeau DB; Chalaoui J; Campeau MP
    Technol Cancer Res Treat; 2015 Dec; 14(6):667-76. PubMed ID: 24988054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case Series of 23 Patients Who Developed Fatal Radiation Pneumonitis After Stereotactic Body Radiotherapy for Lung Cancer.
    Onishi H; Marino K; Yamashita H; Terahara A; Onimaru R; Kokubo M; Shioyama Y; Kozuka T; Matsuo Y; Aruga T; Hiraoka M
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818801323. PubMed ID: 30286697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.